Laboratory Test-Based Biomarkers and Diagnostic Tests in MASH
Detailed reference profiles of routine blood panels, interactive FIB-4 and SAFE calculators, proprietary fibrosis assays, US lab test codes, secondary rule-out panels, and MASLD genetics.
Blood tests are almost always the starting line in liver care because they can be drawn at any local lab. One crucial thing we tell every patient: normal ALT and AST liver enzymes do NOT guarantee an unscarred liver. Combining enzymes with platelets and age (FIB-4), running direct scar-turnover panels (ELF or NIS2+/NASHnext), ruling out look-alike conditions, and knowing your family risk gives a much truer picture.
Tissues of origin and clinical significance of ALT, AST, ALP, and GGT, plus healthy adult and NASPGHAN pediatric sex-specific ALT cutoffs.
How portal hypertension and reduced thrombopoietin lower platelet counts (<150,000/uL), plus published F4 cirrhosis sensitivity/specificity cutoffs.
Exact FIB-4 formula, interactive calculator, pediatric (<18 y) contraindication alert, and age-specific thresholds (ages 35–64 vs >=65).
Seven-variable Steatosis-Associated Fibrosis Estimator (SAFE) formula, interactive calculator, and rule-out (<0) / rule-in (>=100) cutoffs for >=F2 fibrosis.
Direct extracellular-matrix biomarkers (HA, PIIINP, TIMP-1), FDA prognostic authorization, and published F0/1 through F4 cutoffs.
10-biomarker panel generating FibroTest, SteatoTest 2, and NashTest 2 readouts alongside published >=F2, >=F3, and F4 cutoffs.
Actionable US clinical ordering directory with Labcorp (including NASHnext/NIS2+ & PEth), Mayo Clinic Labs, and Quest test and reflex codes.
Overview of APRI, NFS, automated Elecsys PRO-C3 (ADAPT), OWLiver (MASEF), LIVERFASt, and NIS2+ / NASHnext.
Step-by-step decoder for ruling out viral hepatitis, hemochromatosis vs. metabolic high ferritin, low-titer ANA vs. autoimmune hepatitis, AAT, celiac, and Wilson disease.
How PNPLA3 I148M, TM6SF2, MBOAT7, protective HSD17B13, and SERPINA1 shape MASH risk — plus AASLD's 12x risk screening rule for first-degree relatives of cirrhosis.